Evidence map›Paper›PMID 36833429›Full record

ArticleGenes2023

Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in

Irene Hidalgo Mayoral, Ainhoa Almeida Santiago, Jose Manuel Sánchez-Zapardiel, Beatriz Hidalgo Calero, Miguel de la Hoya, Alicia Gómez-Sanz, Montserrat de Miguel Reyes, Luis Robles

Abstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Irene Hidalgo MayoralHereditary Cancer Laboratory, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0002-9104-4767
Ainhoa Almeida SantiagoHereditary Cancer Laboratory, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Jose Manuel Sánchez-ZapardielHereditary Cancer Laboratory, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-5516-4430
Beatriz Hidalgo CaleroHereditary Cancer Laboratory, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Miguel de la HoyaMolecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain.ORCID 0000-0002-8113-1410
Alicia Gómez-SanzMolecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain.
Montserrat de Miguel ReyesHereditary Cancer Laboratory, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Luis RoblesMedical Oncology Service, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary breast and ovarian cancer syndrome (HBOC) is a clinical entity characterized by an increased risk of developing breast and ovarian cancer. The genetic diagnosis is based on the identification of heterozygous germinal variants in HBOC susceptibility genes. However, it has recently been described that constitutional mosaic variants can contribute to the aetiology of HBOC. In constitutional mosaicism, individuals have at least two genotypically distinct populations of cells that arise from an early post-zygote event. The mutational event occurs early enough in development to affect several tissues. It is detected in germinal genetic studies as low variant allele frequency (VAF) variants (<30%) that are generally overlooked during the prioritization process. Constitutional mosaic variants can affect both somatic and germinal cells, and thus can be passed to the offspring and have important consequences for genetic counselling. In this work, we report the c.9648+1G>A mosaic variant in the

Indexed as

Hereditary Breast and Ovarian Cancer SyndromeOvarian NeoplasmsBRCA2 ProteinFemaleGenes, BRCA2HumansMosaicismMutationBRCA2 ProteinBRCA2 protein, humanBRCA2constitutional mosaicismHBOC

Identifiers

PMID36833429
PMCPMC9957471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.